Pharminent

Janssen Biotech files US regulatory application for Sirukumab in rheumatoid arthritis

Janssen Biotech is seeking approval for sirukumab in the US to treat adults with moderately to severely active rheumatoid arthritis (RA). http://processandproduction.pharmaceutical-business-review.com/news/janssen-biotech-files-us-regulatory-application-for-sirukumab-in-rheumatoid-arthritis-260916-5014980

Filed under: Arthritis